arabinose has been researched along with Diabetes Mellitus, Type 2 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Q; Li, X; Lu, Y; Ma, S; Pang, X; Shen, D; Sun, J; Tian, S | 1 |
| Gao, J; Li, J; Lyu, B; Piao, C; Swallah, MS; Wang, S; Yu, H; Zhang, J; Zhang, T | 1 |
| Beerens, K; Desmet, T; Grootaert, C; Rajkovic, A; Van Camp, J; van Laar, A | 1 |
| Liu, J; Wang, X; Wang, Z; Xiang, X; Yang, Y; Yao, X; Yi, Y; Ying, Y | 1 |
| Asano, N; Miwa, I; Mizutani, T; Nakajima, H; Taguchi, T; Yabuuchi, M; Yamashita, E | 1 |
| Fosgerau, K; Grunnet, N; Kristiansen, M; Lundgren, K; Quistorff, B; Westergaard, N | 1 |
| Breinholt, J; Fosgerau, K; McCormack, JG; Westergaard, N | 1 |
7 other study(ies) available for arabinose and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Effects of L-arabinose by hypoglycemic and modulating gut microbiome in a high-fat diet- and streptozotocin-induced mouse model of type 2 diabetes mellitus.
Topics: Animals; Arabinose; Diabetes Mellitus, Type 2; Diet, High-Fat; Gastrointestinal Microbiome; Hypoglycemic Agents; Mice; Mice, Inbred C57BL; Streptozocin | 2021 |
Oat β-glucan and L-arabinose synergistically ameliorate glucose uptake in insulin-resistant HepG2 cells and exert anti-diabetic activity
Topics: Animals; Arabinose; beta-Glucans; Blood Glucose; Dexamethasone; Diabetes Mellitus, Type 2; Glucose Transport Proteins, Facilitative; Hep G2 Cells; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Mice; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction | 2022 |
Rare Sugar Metabolism and Impact on Insulin Sensitivity along the Gut-Liver-Muscle Axis In Vitro.
Topics: Arabinose; Caco-2 Cells; Diabetes Mellitus, Type 2; Disaccharides; Glucose; Humans; Insulin; Insulin Resistance; Liver; Muscle, Skeletal | 2023 |
[Effect of L-arabinose on glucose and lipid metabolism in type 2 diabetic rats].
Topics: Animals; Arabinose; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Lipid Metabolism; Lipids; Male; Rats; Rats, Wistar | 2012 |
Hepatic glycogen breakdown is implicated in the maintenance of plasma mannose concentration.
Topics: Administration, Oral; Alanine; Animals; Arabinose; Blood Glucose; Chlorogenic Acid; Diabetes Mellitus, Type 2; Disease Models, Animal; Epinephrine; Glucose; Glucose-6-Phosphatase; Glycogen; Glycogen Phosphorylase; Hexosephosphates; Imino Furanoses; Injections, Intravenous; Insulin; Lactic Acid; Liver; Male; Mannose; Models, Biological; Rats; Rats, Inbred Strains; Rats, Wistar; Sugar Alcohols | 2005 |
Kinetic and functional characterization of 1,4-dideoxy-1, 4-imino-d-arabinitol: a potent inhibitor of glycogen phosphorylase with anti-hyperglyceamic effect in ob/ob mice.
Topics: Animals; Arabinose; Blood Glucose; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Glucagon; Glycogen; Hypoglycemic Agents; Imino Furanoses; In Vitro Techniques; Kinetics; Lactic Acid; Liver; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C57BL; Mice, Obese; Muscles; Phosphorylases; Rabbits; Rats; Sugar Alcohols; Swine | 2000 |
Evidence against glycogen cycling of gluconeogenic substrates in various liver preparations.
Topics: Animals; Arabinose; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Glycogen; Glycogen Phosphorylase; Hepatocytes; Imino Furanoses; Kinetics; Lactic Acid; Liver; Magnetic Resonance Spectroscopy; Male; Perfusion; Rats; Rats, Sprague-Dawley; Sugar Alcohols; Time Factors | 2002 |